Utrecht Health Seed Fund (UHSF) is a Netherlands-based investment fund that provides seed investments to early-stage health startups. They have invested in companies like TargED Biopharmaceuticals, a biotech spin-off from the University Medical Center Utrecht, which is developing Microlyse, a novel thrombolytic drug.
Is Utrecht Health Seed Fund the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Utrecht Health Seed Fund, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed
First ticket size
€1,350,000 - €1,350,000
When reaching out to Utrecht Health Seed Fund, founders should highlight strong scientific validation and a clear path to clinical impact, as the fund values translational potential and partnerships with leading academic institutions. Demonstrating early traction with research hospitals or healthcare providers, as well as a credible regulatory and commercialization strategy, will resonate. Emphasize how your solution addresses unmet medical needs and aligns with the Dutch health innovation ecosystem.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.